Vilanterol Trifenatate/Fluticasone Furoate/Glycopyrronium Bromide

三苯乙酸维兰特罗/糠酸氟替卡松/格隆溴铵

Report date: 2025/11/14 13:58:58

Base Information

Drug NameVilanterol Trifenatate/Fluticasone Furoate/Glycopyrronium Bromide
Drug Alias NameVilfuro-GVilfuro-G
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptorMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsPulmonary Disease, Chronic Obstructive
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2023/11/23
Country/TerritoryIndiaMainland China
CombinationsYes Vilanterol TrifenatateFluticasone FuroateGlycopyrronium Bromide
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLupin Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLupin LtdJiangxi Aishite Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A